Health Technology Assessment (HTA)

​The Commercial team is responsible for supporting our HTA Taskforce which is made up of senior representatives of member companies who lead on pricing and reimbursement, as well as health technology assessment within the UK.

These assessments are undertaken by the National Institute for Health and Clinical Excellence (NICE) for England and Wales, by the Scottish Medicines Consortium (SMC) and the All Wales Medicines Strategy Group (AWMSG). 

In the run-up to changes to the pricing and reimbursement environment in 2014, this Taskforce is responsible for optimising the market access environment for medicines in the UK. The group holds regular dialogues and discussions with all the key reimbursement agencies across the UK.

Print this page icon Print this page
Please choose the subject of your enquiry from the list below:
Code to enter for submitting the form
Enter the above code here:
Can't read? Try different words.